Literature DB >> 25687983

Organ damage in patients with incomplete lupus syndromes: from a Chinese academic center.

Zhen Chen1, Meng-Tao Li, Dong Xu, Xiao-Mei Leng, Qian Wang, Xin-Ping Tian, Shang-Zhu Zhang, Yan Zhao, Xiao-Feng Zeng.   

Abstract

With this study, we provide insight into the clinical characteristics, laboratory characteristics, and organ damage associated with incomplete lupus syndromes (ILE) and search for predictors of organ damage in ILE. A retrospective chart review was performed on 77 hospitalized patients with ILE. The control patient group comprised 2104 systemic lupus erythematosus (SLE) patients who were entered into the Chinese SLE Treatment and Research group (CSTAR). The Systemic Lupus International Collaborating Clinics (SLICC)/ACR Damage Index (SDI) was used to classify damage features. Based on their SDI score, ILE patients were divided into SDI > 0 and SDI = 0 groups. The percentages of anti-SSA-seropositive (54.5 %) and anti-RNP-seropositive (24.7 %) patients with ILE were higher than those found among the SLE patients from CSTAR (p < 0.001). The mean SDI score was 0.66 (range 0-2), and a damage score greater than 0 was present in 41 (53.3 %) patients. The most prevalent damage category was pulmonary damage, present in 17 (22.1 %) patients. Peripheral vascular damage occurred in individuals who were significantly older than those who had musculoskeletal damage (p = 0.031). The subgroup with SDI > 0 had a higher mean age (36.8 ± 2.04 years) than those with SDI = 0 (30.8 ± 2.08 years; p = 0.044). The mean SLEDAI score in the SDI > 0 patient group (8.2 ± 0.74) was higher than that of the SDI = 0 group (4.8 ± 0.54; p = 0.001). ILE patients may include a subset that is likely to experience progressive organ damage. Organ damage was more common in patients of older age and with high SLEDAI scores.

Entities:  

Mesh:

Year:  2015        PMID: 25687983     DOI: 10.1007/s10067-015-2884-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  27 in total

Review 1.  Undifferentiated CTD: a wide spectrum of autoimmune diseases.

Authors:  Marta Mosca; Chiara Tani; Linda Carli; Stefano Bombardieri
Journal:  Best Pract Res Clin Rheumatol       Date:  2012-02       Impact factor: 4.098

Review 2.  Lupus organ damage: what is damaged in Asian patients?

Authors:  W P Kuan; E K Li; L-S Tam
Journal:  Lupus       Date:  2010-10       Impact factor: 2.911

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT).

Authors:  A J Swaak; H van de Brink ; R J Smeenk; K Manger; J R Kalden; S Tosi; A Marchesoni; Z Domljan; B Rozman; D Logar; G Pokorny; L Kovacs; A Kovacs; P G Vlachoyiannopoulos; H M Moutsopoulos; H Chwalinska-Sadowska; B Dratwianka; E Kiss; N Cikes; B Anic; M Schneider; R Fischer; S Bombardieri; M Mosca; W Graninger; J S Smolen
Journal:  Rheumatology (Oxford)       Date:  2001-01       Impact factor: 7.580

5.  Organ damage in high-risk patients with systemic and incomplete lupus syndromes.

Authors:  Nancy J Olsen; Maha Yousif; Azza Mutwally; Melinda Cory; Nada Elmagboul; David R Karp
Journal:  Rheumatol Int       Date:  2013-05-30       Impact factor: 2.631

6.  Damage accrual in southern Chinese patients with systemic lupus erythematosus.

Authors:  Chi Chiu Mok; Carmen Tze Kwan Ho; Raymond Woon Sing Wong; Chak Sing Lau
Journal:  J Rheumatol       Date:  2003-07       Impact factor: 4.666

7.  Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage.

Authors:  G S Alarcón; J M Roseman; G McGwin; A Uribe; H M Bastian; B J Fessler; B A Baethge; A W Friedman; J D Reveille
Journal:  Rheumatology (Oxford)       Date:  2003-08-15       Impact factor: 7.580

8.  Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.

Authors:  D D Gladman; C H Goldsmith; M B Urowitz; P Bacon; C Bombardier; D Isenberg; K Kalunian; M H Liang; P Maddison; O Nived
Journal:  J Rheumatol       Date:  1994-08       Impact factor: 4.666

Review 9.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

10.  Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study.

Authors:  T Stoll; N Sutcliffe; J Mach; R Klaghofer; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2004-05-25       Impact factor: 7.580

View more
  5 in total

Review 1.  Preclinical lupus.

Authors:  Rebecka Bourn; Judith A James
Journal:  Curr Opin Rheumatol       Date:  2015-09       Impact factor: 5.006

2.  Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls.

Authors:  Teresa Aberle; Rebecka L Bourn; Melissa E Munroe; Hua Chen; Virginia C Roberts; Joel M Guthridge; Krista Bean; Julie M Robertson; Kathy L Sivils; Astrid Rasmussen; Meghan Liles; Joan T Merrill; John B Harley; Nancy J Olsen; David R Karp; Judith A James
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-11-14       Impact factor: 4.794

Review 3.  Differentiating between UCTD and early-stage SLE: from definitions to clinical approach.

Authors:  Savino Sciascia; Dario Roccatello; Massimo Radin; Ioannis Parodis; Jinoos Yazdany; Guillermo Pons-Estel; Marta Mosca
Journal:  Nat Rev Rheumatol       Date:  2021-11-11       Impact factor: 20.543

Review 4.  Incomplete Systemic Lupus Erythematosus: What Remains After Application of American College of Rheumatology and Systemic Lupus International Collaborating Clinics criteria?

Authors:  Wietske M Lambers; Johanna Westra; Marcel F Jonkman; Hendrika Bootsma; Karina de Leeuw
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-05       Impact factor: 4.794

Review 5.  Finding lupus in the ANA haystack.

Authors:  Nancy J Olsen; David R Karp
Journal:  Lupus Sci Med       Date:  2020-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.